Isaac Ben-Bassat Selected Research

Dual Specificity Phosphatase 1

10/2003	Dual-specificity phosphatase Pyst2-L is constitutively highly expressed in myeloid leukemia and other malignant cells.
9/2003	Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia.
1/2003	cDNA microarray analysis reveals an overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isaac Ben-Bassat Research Topics

Disease

7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2012 - 01/2003
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2014 - 02/2002
4	Hematologic Neoplasms (Hematological Malignancy) 07/2009 - 01/2002
3	Infections 05/2009 - 10/2008
3	Leukemia 10/2003 - 01/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010 - 10/2003
2	Agammaglobulinemia (Hypogammaglobulinemia) 05/2009 - 10/2008
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2009 - 10/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2009 - 10/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2007 - 08/2003
2	Lymphoma (Lymphomas) 04/2007 - 08/2003
2	Neoplasms (Cancer) 12/2006 - 10/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2014
1	Invasive Fungal Infections 06/2012
1	Bacteremia 06/2012
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2009
1	Multiple Myeloma 05/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2009
1	Paraproteinemias (Monoclonal Gammopathy) 05/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2009
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 05/2009
1	Reinfection 05/2009
1	Disease Progression 04/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2009
1	Cytokine Release Syndrome 04/2009
1	Leukopenia 04/2009
1	Splenomegaly 04/2009
1	Thrombocytopenia (Thrombopenia) 04/2009
1	Cytopenia 04/2009
1	Thrombotic Microangiopathies 07/2004
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2003
1	Neutropenia 08/2003
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2002
1	Autoimmune Diseases (Autoimmune Disease) 01/2002
1	Proteinuria 01/2002
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2002
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2002

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 08/2014 - 08/2003
4	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 02/2002
4	Intravenous Immunoglobulins (IVIG)FDA Link 05/2009 - 08/2003
3	Immunoglobulins (Immunoglobulin)IBA 05/2009 - 10/2008
3	Dual Specificity Phosphatase 1IBA 10/2003 - 01/2003
2	Tyrosine Kinase InhibitorsIBA 09/2014 - 01/2013
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2012 - 09/2011
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2014
1	FluorineIBA 08/2014
1	Monoclonal AntibodiesIBA 07/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2009
1	ibritumomab tiuxetan (Zevalin)FDA Link 04/2007
1	Messenger RNA (mRNA)IBA 10/2003
1	Mitogen-Activated Protein KinasesIBA 10/2003
1	Dual-Specificity PhosphatasesIBA 10/2003
1	Proteins (Proteins, Gene)FDA Link 10/2003
1	Busulfan (Busulfex)FDA Link 05/2003
1	Complementary DNA (cDNA)IBA 01/2003
1	AutoantibodiesIBA 01/2002
1	CytokinesIBA 01/2002
1	AntibodiesIBA 01/2002
1	InterferonsIBA 01/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 06/2012 - 08/2003
4	Therapeutics 07/2010 - 01/2002
3	Stem Cell Transplantation 04/2007 - 08/2003
2	Hematopoietic Stem Cell Transplantation 02/2009 - 10/2008
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2004 - 06/2004
1	Transplantation 05/2009
1	Homologous Transplantation 05/2003
1	Remission Induction 01/2003